Formulation and characterization of sustained released tablet of deflazacort for colon targeting
Abstract
Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. Deflazacort are commonly Prescribed for the patient in disease condition such as Inflammatory Bowel Disease (IBD) ulcerative colitis (UC) and Crohn’s disease (CD). Delivery of drug substances to the ileo-colonic region may be an essential element of successful drug treatment (improved efficacy or reduced systemic toxicity) in topical treatment of the colon. The colon targeted drug delivery can also be used for effective treatment of diseases. This may improve efficacy of drug treatment, decrease in dose to be administered, improved drug utilization. It is a promising site for a drug which is unstable or poorly absorbed. Currently available formulation of deflazacort is conventional solid dosage form (6, 12, 18 & 30 mg tablets). Dosage form require frequent dose of administration due to its short half life of 1.1-1.9 hrs. So, present study is aimed to develop an colon targeted sustained release dosage form has been developed as these releases the drug slowly into the ileo- colonic region and maintain constant drug concentration in the serum for longer period of time.
Keywords: Deflazacort, Colon Targeting, IBD, Crohn’s Disease
Downloads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.